New tool tracks unintended CRISPR edits and their effects in individual cells
Salk Institute researchers unveil Superb-seq, a single-cell method that simultaneously maps CRISPR on- and off-target edits alongside resulting gene-expression changes.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Coverage from Nature, Phys.org, Tech Times, Onco'Zine, Bioengineer.org and the Salk Institute's own announcement describes a new technique called Superb-seq that captures both CRISPR-Cas9 editing outcomes and whole transcriptomes in the same individual cell. According to the reports, the method was applied to human cells edited with Cas9, revealing 36 unintended off-target sites across the genome. One of these off-target sites was linked to expression changes in MYC, a well-studied cancer-related gene, marking the first time an off-target edit has been directly tied to a functional transcriptional consequence in single cells. The Nature paper presents the technical workflow, which combines targeted DNA amplification with single-cell RNA sequencing to correlate specific edit patterns with gene-expression profiles cell by cell.
The coverage emphasizes the dual-resolution capability of Superb-seq: it detects where edits occur and simultaneously measures how those edits alter the transcriptome in the very same cell. Nature's article details the experimental design and validation steps, while Phys.org and the Salk Institute release highlight the safety implications for therapeutic genome editing. Tech Times and Onco'Zine focus on the MYC finding, noting that the off-target effect on a proto-oncogene underscores the need for comprehensive off-target profiling before clinical deployment. Bioengineer.org provides a technical summary of the library preparation and computational pipeline used to align DNA edits with RNA reads.
Background context from the coverage indicates that existing off-target detection methods — such as GUIDE-seq, CIRCLE-seq and DISCOVER-seq — typically operate on bulk cell populations and cannot link a specific edit to its phenotypic consequence in the same cell. Single-cell RNA sequencing alone cannot distinguish edited from unedited cells without parallel DNA information. Superb-seq addresses this gap by co-assaying DNA and RNA, enabling researchers to observe heterogeneous editing outcomes and their transcriptional ripple effects across a cell population. The MYC association is particularly notable because MYC dysregulation is implicated in numerous cancers, raising questions about the oncogenic risk of unintended edits near this locus.
What to watch next: the coverage states that the Salk team plans to apply Superb-seq to additional guide RNAs, cell types and delivery modalities to build a broader atlas of off-target effects. Nature's paper mentions ongoing work to adapt the method for in vivo edited tissues and for base-editing and prime-editing systems. Regulatory implications are not discussed in the coverage, but the ability to demonstrate single-cell resolution of both edits and expression changes may inform future guidance on preclinical safety assessment for CRISPR therapeutics.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 51m ago.
Quick answers
What is Superb-seq?
Superb-seq is a single-cell sequencing method developed at the Salk Institute that simultaneously captures CRISPR-Cas9 on- and off-target DNA edits and the full transcriptome in the same cell.
How many off-target sites were detected?
The coverage reports 36 unintended off-target sites identified in the study.
Which cancer-related gene was affected?
An off-target edit was linked to expression changes in MYC, a proto-oncogene associated with many cancers.
Coverage (6)
- Can genome editing be safer and more effective? Salk Institute · 2d ago
- CRISPR Off-Target Edits: Salk's Superb-seq Finds 36 Unintended Sites, One Tied to MYC Gene Changes Tech Times · 2d ago
- Single-Cell Study Reveals Unexpected CRISPR-Cas9 Edits Affecting a Cancer-Related Gene Onco'Zine · 2d ago
- Superb-seq Detects On- and Off-Target CRISPR Edits at Single-Cell Resolution Bioengineer.org · 2d ago
- Joint single-cell capture of Cas9 edits and transcriptomes reveals on- and off-target effects on gene expression Nature · 2d ago
- New tool tracks unintended CRISPR edits and their effects in individual cells Phys.org · 2d ago
Topics
Related trends
Anthropic CEO says AI could cure most major diseases within next decade
Anthropic reports its AI model Claude discovered a novel CRISPR-like enzyme system.
A transplanted pig kidney buys time for a human one to become available
A genetically modified pig kidney functioned in a human body for a record nine months as a bridge to a human transplant.
Gene-edited beagles may offer a future option for people with dog allergies
Kindred Companion Sciences has used CRISPR gene-editing to create hypoallergenic beagles by removing a major allergy-causing protein.
Scientists edit human DNA inside the body for the first time
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Gene therapy that led to boy’s death had limited efficacy
Recent coverage examines a fatal gene-editing trial in China that showed limited efficacy alongside severe safety concerns.
A first for CRISPR: powerful prime editing alters DNA directly in the human body
Scientists have conducted the first-ever test of prime editing to alter DNA directly inside the human body, potentially offering a cure for genetic diseases.